Physician's Weekly
JUNE 14, 2025
Researchers conducted a retrospective study to examine the outcomes and natural history of asymptomatic renal stones managed by observation following RC and UD. They reviewed individuals referred for RC and UD between 2015 and 2023 at a single center. The mean stone burden was 4.5 mm (SD ± 2.75).
Physician's Weekly
JUNE 15, 2025
Data was collected from 22 centers across North and South America, Asia, and Europe, following STROBE reporting guidelines. The AQP4-NMOSD individuals with CVC/RF had higher ON relapse rates than those with AID (1.06 ± 3.33 The dataset, acquired between 2000 and 2018, comprised OCT and clinical metadata. In MOGAD (n = 49), 40.8%
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Family Physicians of St. Joseph
SEPTEMBER 25, 2018
Larger companies now dominate the healthcare landscape, yet through innovation and a dedication to exceptional patient care, Family Physicians of St. They have remained independent and committed to caring for patients as a small practice, all the while introducing new ideas and setting new standards in Michigan’s Great Southwest.
The Clinical Problem Solvers
JUNE 26, 2023
Dr. Saha’s research focuses broadly on the influence of race and racism in the doctor-patient relationship, its relation to disparities in the quality of health care, and its implications for diversity in the healthcare workforce. He has also served as a Council member and Secretary of SGIM. She also is the 2017 recipient of the George L.
FDA Law Blog
JUNE 23, 2021
Valentine — For the last 13 years, this blogger has been at the center of what has now been dubbed “patient-focused drug development.” For 6 years, I served as a patient liaison within FDA in what was then called the Office of Special Health Issues. By James E. The practice of medicine was viewed as paternalistic.
FDA Law Blog
NOVEMBER 1, 2023
The PR first sets out to establish that it has authority to regulate in vitro diagnostic “test systems” as devices, and not just the system’s individual components, such as reagents, instruments, specimen collection devices, and software. FDA’s position is, however, only one side of the story.
FDA Law Blog
JANUARY 26, 2022
In defending the complete broadcast, Lilly called out similar elements from each of the individual components as demonstrating its intent to have all three viewed sequentially. And in this case the presentation would be compliant whether each component was shown individually, or, when combining all three sequentially.
Expert insights. Personalized for you.
52 
Let's personalize your content